Journal of Renal Nutrition
Volume 17, Issue 3 , Pages 167-172, May 2007

Kidney Growth During Catabolic Illness: What It Does Not Destroy Makes It Grow Stronger

  • Harold A. Franch, MD

      Affiliations

    • Research Service, Atlanta Department of Veterans Affairs Medical Center, Decatur, Georgia.
    • Renal Division, Emory University School of Medicine, Atlanta, Georgia.
    • Corresponding Author InformationAddress reprint requests to Harold A. Franch, MD, Renal Division, Emory University School of Medicine, WMB, Room 338, 1639 Pierce Drive NE, Atlanta, GA 30322.

The kidney undergoes hypertrophy under conditions that paradoxically cause a loss of lean body mass, such as diabetes, acidosis, and chronic kidney disease. What unique mechanisms account for kidney growth during negative nitrogen balance? One adaptation is that renal tubular cells substantially decrease protein breakdown during kidney cell growth. In this review, we discuss how acidosis and diabetes reduce protein breakdown within the kidney and the intracellular signaling pathways that may regulate protein metabolism. Our results suggest that in cell culture models and in acute diabetes, kidney cells specifically reduce protein breakdown by the lysosomal pathway of chaperone-mediated autophagy. This differs from the activation of proteolysis by the ubiquitin-proteasome system in muscle in acute diabetes and uremia. A shared signaling pathway regulates protein breakdown in both kidney and skeletal muscle, namely, phosphatidylinositol-3 kinase signaling. Diabetes mellitus activates signaling through this pathway in the kidney while down-regulating it in skeletal muscle. We conclude that similar signaling pathways may regulate distinct proteolytic pathways in different tissues.

 

 This work reviewed here was made possible by a Merit Review Award from the United States Department of Veterans Affairs.

PII: S1051-2276(07)00004-0

doi:10.1053/j.jrn.2007.01.018

Journal of Renal Nutrition
Volume 17, Issue 3 , Pages 167-172, May 2007